The Class I recall status indicates that the product poses a risk of causing serious health consequences or death if consumed ...

The panelists said that vaginal creams and other localized therapies for menopause are safe and vastly underused by women who could benefit.

When the U.S. Food and Drug Administration (FDA) convened a public expert panel to review the use of selective serotonin ...

An FDA-cleared predictive analytic tool for hemodynamic instability may soon leverage its success in critical care to the ...

Sarepta Therapeutics is refusing to pull its gene therapy Elevidys (delandistrogene moxeparvovec), despite a request from the FDA.

Members of an FDA expert panel discussed the risks and benefits of selective serotonin reuptake inhibitors, or SSRIs, for ...

As my colleague Kiera Butler has written, Kennedy has claimed, without evidence, that they can cause addiction and school ...

An agency-sponsored forum included critics of psychiatry who believe the drugs can harm a developing fetus. Other experts ...

The FDA subsequently issued a Class I risk classification for the recall on July 8. Newsweek contacted Fuentes Farms LLC for comment by email outside of regular working hours.

New data have further strengthened the link between human immune globulin products and the risk for thrombosis, prompting action by the US Food and Drug Administration (FDA). "Additional caution ...